Showing results (311-320 of 327) with videos related to

Sort By:
Pageof 33
Neurology|July 1, 1997
What are the obstacles for an accurate clinical diagnosis of Pick's disease? A clinicopathologic studyI Litvan, Y Agid, N Sastry, et al.
Archives of Neurology|July 25, 1998
Accuracy of the clinical diagnoses of Lewy body disease, Parkinson disease, and dementia with Lewy bodies: a clinicopathologic studyI Litvan, A MacIntyre, C G Goetz, et al.
Biorxiv : the Preprint Server for Biology|July 1, 2025
EGR3 Deletion Rescues Developmental and Epileptic Encephalopathy in Kcna1 -null MiceArindam Ghosh Mazumder, Saifina Karedia, Nandani Adhyapak, et al.
Neurology|September 26, 1997
Botulinum toxin type B: a double-blind, placebo-controlled, safety and efficacy study in cervical dystoniaM F Lew, B T Adornato, D D Duane, et al.
Neurology|December 30, 2004
Clinical evaluation of idiopathic paroxysmal kinesigenic dyskinesia: new diagnostic criteriaM K Bruno, M Hallett, K Gwinn-Hardy, et al.
Neurology|July 26, 2000
Paroxysmal kinesigenic dyskinesia and infantile convulsions: clinical and linkage studiesK J Swoboda, B Soong, C McKenna, et al.
Neurogenetics|August 29, 2001
Novel mutation in the TOR1A (DYT1) gene in atypical early onset dystonia and polymorphisms in dystonia and early onset parkinsonismJ C Leung, C Klein, J Friedman, et al.
Anesthesiology|July 23, 2015
N-terminal pro-B-type Natriuretic Peptides' Prognostic Utility Is Overestimated in Meta-analyses Using Study-specific Optimal Diagnostic ThresholdsDanielle Potgieter, Dale Simmers, Lisa Ryan, et al.
Neurology|June 9, 2004
Apolipoprotein E controls the risk and age at onset of Parkinson diseaseY J Li, M A Hauser, W K Scott, et al.
Elife|January 6, 2025
Plural molecular and cellular mechanisms of pore domain KCNQ2 encephalopathyTimothy J Abreo, Emma C Thompson, Anuraag Madabushi, et al.
Pageof 33